80 related articles for article (PubMed ID: 33867130)
1. Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection.
Hou J; Wei Y; Zou J; Jaffery R; Sun L; Liang S; Zheng N; Guerrero AM; Egan NA; Bohat R; Chen S; Zheng C; Mao X; Yi SS; Chen K; McGrail DJ; Sahni N; Shi PY; Chen Y; Xie X; Peng W
Nat Commun; 2024 Jan; 15(1):109. PubMed ID: 38168026
[TBL] [Abstract][Full Text] [Related]
2. Role of early growth response 1 in inflammation-associated lung diseases.
Zou K; Zeng Z
Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L143-L154. PubMed ID: 37401387
[TBL] [Abstract][Full Text] [Related]
3. Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target.
Yang Z; Nicholson SE; Cancio TS; Cancio LC; Li Y
Front Immunol; 2023; 14():1100461. PubMed ID: 37006238
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection.
Nakayama T; Azegami T; Kiso M; Imai M; Uraki R; Hayashi K; Hishikawa A; Yoshimoto N; Nakamichi R; Sugita-Nishimura E; Yoshida-Hama E; Kawaoka Y; Itoh H
Sci Rep; 2023 Feb; 13(1):3103. PubMed ID: 36813909
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model.
Chen YT; Chang YH; Pathak N; Tzou SC; Luo YC; Hsu YC; Li TN; Lee JY; Chen YC; Huang YW; Yang HJ; Hsu NY; Tsai HP; Chang TY; Hsu SC; Liu PC; Chin YF; Lin WC; Yang CM; Wu HL; Lee CY; Hsu HL; Liu YC; Chu JW; Wang LH; Wang JY; Huang CH; Lin CH; Hsieh PS; Wu Lee YH; Hung YJ; Yang JM
Front Immunol; 2022; 13():1080897. PubMed ID: 36618412
[TBL] [Abstract][Full Text] [Related]
6. Serum Proteomic Analysis for New Types of Long-Term Persistent COVID-19 Patients in Wuhan.
Li C; Yue L; Ju Y; Wang J; Chen M; Lu H; Liu S; Liu T; Wang J; Hu X; Tuohetaerbaike B; Wen H; Zhang W; Xu S; Jiang C; Chen F
Microbiol Spectr; 2022 Dec; 10(6):e0127022. PubMed ID: 36314975
[TBL] [Abstract][Full Text] [Related]
7. SERPINE1 Gene Is a Reliable Molecular Marker for the Early Diagnosis of Aortic Dissection.
Li D; Xiao CS; Chen L; Wu Y; Jiang W; Jiang SL
Evid Based Complement Alternat Med; 2022; 2022():5433868. PubMed ID: 35836829
[TBL] [Abstract][Full Text] [Related]
8. A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients.
Huang P; Zuo Q; Li Y; Oduro PK; Tan F; Wang Y; Liu X; Li J; Wang Q; Guo F; Li Y; Yang L
Front Immunol; 2022; 13():930673. PubMed ID: 35784318
[TBL] [Abstract][Full Text] [Related]
9. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.
Ning Q; Wu D; Wang X; Xi D; Chen T; Chen G; Wang H; Lu H; Wang M; Zhu L; Hu J; Liu T; Ma K; Han M; Luo X
Signal Transduct Target Ther; 2022 Feb; 7(1):57. PubMed ID: 35197452
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients.
Thangaraju K; Katneni U; Akpan IJ; Tanaka K; Thomas T; Setua S; Reisz JA; Cendali F; Gamboni F; Nemkov T; Kahn S; Wei AZ; Valk JE; Hudson KE; Roh DJ; Moriconi C; Zimring JC; D'Alessandro A; Spitalnik SL; Francis RO; Buehler PW
Front Med (Lausanne); 2021; 8():817305. PubMed ID: 35087853
[TBL] [Abstract][Full Text] [Related]
11. Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin.
Bosch-Barrera J; Roqué A; Teixidor E; Carmona-Garcia MC; Arbusà A; Brunet J; Martin-Castillo B; Cuyàs E; Verdura S; Menendez JA
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056076
[TBL] [Abstract][Full Text] [Related]
12. Age and genotype dependent erythropoietin protection in COVID-19.
Papadopoulos KI; Sutheesophon W; Manipalviratn S; Aw TC
World J Stem Cells; 2021 Oct; 13(10):1513-1529. PubMed ID: 34786155
[TBL] [Abstract][Full Text] [Related]
13. PTSD as an Endothelial Disease: Insights From COVID-19.
Sfera A; Osorio C; Rahman L; Zapata-Martín Del Campo CM; Maldonado JC; Jafri N; Cummings MA; Maurer S; Kozlakidis Z
Front Cell Neurosci; 2021; 15():770387. PubMed ID: 34776871
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19.
Kellici TF; Pilka ES; Bodkin MJ
Trends Pharmacol Sci; 2021 Jun; 42(6):431-433. PubMed ID: 33867130
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Infection and C1-Esterase Inhibitor: Camouflage Pattern and New Perspective.
Al-Kuraishy HM; Al-Gareeb AI; Jalal NA; Kabrah SM; Alexiou A; Batiha GE
Curr Protein Pept Sci; 2022; 23(7):465-474. PubMed ID: 35959625
[TBL] [Abstract][Full Text] [Related]
16. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
Choudhury R; Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Talmor DS; Nydam TL; Yaffe MB
World J Emerg Surg; 2020 Apr; 15(1):29. PubMed ID: 32312290
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Acute Respiratory Distress Syndrome: Pathways to Precision.
Giannini HM; Meyer NJ
Crit Care Clin; 2021 Oct; 37(4):817-834. PubMed ID: 34548135
[TBL] [Abstract][Full Text] [Related]
19. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
